Biological: Benralizumab, Biological: Placebo to Mepolizumab ( DrugBank: Mepolizumab, Benralizumab )
1 disease
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
44 | Wegener granulomatosis | 0 |
44. Wegener granulomatosis
Clinical trials : 92 / Drugs : 106 - (DrugBank : 27) / Drug target genes : 22 - Drug target pathways : 78
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|